ArticleOncology letters2025
Unusual pulmonary nodules diffusion from epithelial‑myoepithelial carcinoma on
Article in Oncology letters, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Epithelial-myoepithelial carcinoma of the lung: a case report and literature review.Journal of cancer research and clinical oncology · 2026Review
- Epithelial-myoepithelial carcinoma of the nasopharynx: cases report and literature review.Frontiers in oncology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Epithelial-myoepithelial carcinoma (EMC) is a rare low-grade malignant tumor with uncommon regional lymph node metastasis and distant metastasis. The diagnosis of this disease primarily relies on the examination of pathological morphology and immunohistochemical staining, as its clinical symptoms and imaging findings are non-specific. This makes it more difficult to provide specific information about EMC lung metastasis. The present report describes a biopsy-confirmed case of pulmonary metastases arising from EMC of the parotid. The pulmonary nodules were dispersed throughout both lungs and exhibited varying degrees of fluorodeoxyglucose (FDG) uptake on positron emission tomography-computed tomography scans. Additionally, the pathological and immunohistological presentation of the lung mass was similar to that of the primary lesion. Several pulmonary nodules exhibiting varying degrees of FDG uptake may be considered a distinctive sign of metastasis on EMC imaging. Reviewing the present case, along with other similar rare cases in the literature, is crucial to accurately evaluate the imaging examinations of such patients to identify and establish an appropriate treatment plan for potential metastatic lung cancer. It also highlights the importance of not underestimating the malignant potential of EMC and the necessity for close follow-up.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.